Pacer Advisors Inc. increased its holdings in shares of PerkinElmer, Inc. (NYSE:PKI) by 11.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,113 shares of the medical research company’s stock after buying an additional 1,744 shares during the period. Pacer Advisors Inc.’s holdings in PerkinElmer were worth $1,180,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of PKI. Acrospire Investment Management LLC raised its stake in shares of PerkinElmer by 185.7% during the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the medical research company’s stock worth $136,000 after buying an additional 1,300 shares during the last quarter. LS Investment Advisors LLC raised its stake in shares of PerkinElmer by 2.1% during the second quarter. LS Investment Advisors LLC now owns 2,877 shares of the medical research company’s stock worth $196,000 after buying an additional 60 shares during the last quarter. Waldron LP bought a new stake in shares of PerkinElmer during the third quarter worth approximately $200,000. Seaward Management Limited Partnership bought a new stake in shares of PerkinElmer during the third quarter worth approximately $202,000. Finally, Carret Asset Management LLC bought a new stake in shares of PerkinElmer during the second quarter worth approximately $210,000. 90.49% of the stock is owned by institutional investors and hedge funds.
Shares of PerkinElmer, Inc. (NYSE PKI) traded down $0.22 during mid-day trading on Thursday, hitting $73.04. 325,700 shares of the stock traded hands, compared to its average volume of 634,127. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.59 and a quick ratio of 2.09. PerkinElmer, Inc. has a 52 week low of $50.09 and a 52 week high of $73.43. The company has a market capitalization of $8,075.10, a P/E ratio of 26.35, a price-to-earnings-growth ratio of 2.19 and a beta of 0.77.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 9th. Stockholders of record on Friday, January 19th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.38%. The ex-dividend date is Thursday, January 18th. PerkinElmer’s dividend payout ratio is 7.78%.
In other news, Director Peter Barrett sold 7,071 shares of the stock in a transaction on Monday, November 13th. The shares were sold at an average price of $71.07, for a total transaction of $502,535.97. Following the completion of the sale, the director now owns 26,271 shares of the company’s stock, valued at $1,867,079.97. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Nicholas A. Lopardo sold 24,050 shares of the stock in a transaction on Tuesday, November 7th. The stock was sold at an average price of $70.72, for a total transaction of $1,700,816.00. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.
A number of equities research analysts recently weighed in on the stock. Citigroup Inc. reissued a “buy” rating and set a $80.00 price target (up from $74.00) on shares of PerkinElmer in a research note on Tuesday, September 26th. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and issued a $67.00 target price on shares of PerkinElmer in a research note on Tuesday, September 26th. Zacks Investment Research raised shares of PerkinElmer from a “hold” rating to a “buy” rating and set a $74.00 target price for the company in a research note on Tuesday, August 1st. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $81.00 target price on shares of PerkinElmer in a research note on Friday, August 4th. Finally, Cowen and Company reaffirmed a “hold” rating and issued a $70.00 target price on shares of PerkinElmer in a research note on Friday, September 1st. Two analysts have rated the stock with a sell rating, nine have given a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $68.64.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.